Database of Interstitial Lung Diseases
Interstitial Lung Diseases
|Official Title:||Registration of Clinical Data and DNA/Serum of Patients With Interstitial Lung Diseases (ILD)|
|Study Start Date:||January 2006|
Protocol title: 'Registration of clinical data and DNA of patients with Interstitial Lung Disease (ILD)' Rationale: The etiopathogenesis of most Interstitial Lung Diseases (ILDs) is still unknown. Further research, e.g. to determine predisposing genetic factors, is therefore needed. A database with relevant clinical data and DNA/serum samples of ILD patients could facilitate future research on the etiopathogenesis of ILDs.
Objective: Availability of relevant clinical data and DNA/serum samples of ILD patients in a database. Those data can be used for future research.
Study design: A prospective observational study
Study population: Patients diagnosed with ILD attending the pulmonology department in participating hospitals.
Intervention: a blood sample is taken from each patient. Furthermore, additional information is collected from the medical file.
Main study parameters/endpoints: DNA and serum sample, demographic variables, medical information, occupational history and hobbies.
Nature and extent of the burden and risks associated with participation, group relatedness: two tubes of blood will be drawn from the patients. The risks of drawing blood from a vein are minimal.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00267800
|St. Antonius Hospital|
|Nieuwegein, Netherlands, 3435CM|
|Utrecht, Netherlands, 3508 TG|
|Mesos Medisch Centrum|
|Utrecht, Netherlands, 3527 CE|
|Utrecht, Netherlands, 3584 CX|
|Principal Investigator:||J.M.M. van den Bosch, M.D.||St. Antonius Hospital|
|Principal Investigator:||J.C. Grutters, M.D.||St. Antonius Hospital|